First-in-human, phase 1 study of PF-06753512, a vaccine-based immunotherapy regimen (VBIR), in non-metastatic hormone-sensitive biochemical recurrence and metastatic castration-resistant prostate cancer (mCRPC)
==================================================================================================================================================================================================================

* Karen A Autio
* Celestia S Higano
* Luke Nordquist
* Leonard J Appleman
* Tian Zhang
* Xin-Hua Zhu
* Hani Babiker
* Nicholas J Vogelzang
* Sandip M Prasad
* Michael T Schweizer
* Ravi A Madan
* Stephane Billotte
* Nora Cavazos
* Orlaith Bogg
* Ray Li
* Kam Chan
* Helen Cho
* Megan Kaneda
* I-Ming Wang
* Jenny Zheng
* Szu-Yu Tang
* Robert Hollingsworth
* Kenneth A Kern
* Daniel P Petrylak